Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 943.00
+35.00 (3.85%)
Jul 15, 2026, 3:30 PM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 87.33 billion as of July 15, 2026. Its market cap has increased by 9.40% in one year.
Market Cap
87.33B
Enterprise Value
131.57B
Revenue
34.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
943.00
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 87.33B, an increase of 127.45%. That is a compound annual growth rate of 3.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 87.33B | 16.69% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 171.41B |
| PeptiDream | 130.03B |
| SanBio Company | 77.20B |
| Oncolys BioPharma | 73.87B |
| Cuorips | 38.81B |
| Healios K.K. | 35.64B |
| Japan Tissue Engineering | 26.76B |
| AnGes | 20.34B |